Research Description

Overcoming resistance to progestin therapy in endometrial cancer 

Awards

• Predoctoral Training Grant in the Pharmacological Sciences (T32 GM144636), 2024-present

Publications

• Hagemann AR, Hagemann IS, Mutch DG, Devor EJ, Malmrose PK, Zhang Y, Morrison AM, Thiel KW, Leslie KK. Enhancing Progestin Therapy with a Glucagon-Like Peptide 1 Agonist for the Conservative Management of Endometrial Cancer. Cancers (Basel). 2025 Feb 10;17(4):598. doi: 10.3390/cancers17040598. PMID: 40002193; PMCID: PMC11853405

• Colling KE, Symons EL, Buroni L, Sumanasiri HK, Andrew-Udoh J, Witt E, Losh HA, Morrison AM, Leslie KK, Dunnill CJ, de Bono JS, Thiel KW. Multiplexed Live-Cell Imaging for Drug Responses in Patient-Derived Organoid Models of Cancer. J Vis Exp. 2024 Jan 5;(203):10.3791/66072. doi: 10.3791/66072. PMID: 38251777; PMCID: PMC11256050

• Colling KE, Symons EL, Buroni L, Sumanisiri HK, Andrew-Udoh J, Witt E, Losh HA, Morrison AM, Leslie KK, Dunnill CJ, De Bono JS, Thiel KW. Multiplexed live-cell imaging for drug responses in patient-derived organoid models of cancer. bioRxiv [Preprint]. 2023 Nov 17:2023.11.15.567243. doi: 10.1101/2023.11.15.567243. Update in: J Vis Exp. 2024 Jan 5;(203). doi: 10.3791/66072. PMID: 38014133; PMCID: PMC10680710